Less Ads, More Data, More Tools Register for FREE

Pin to quick picksToyota Motor Regulatory News (TYT)

Share Price Information for Toyota Motor (TYT)

Share Price is delayed by 15 minutes
Get Live Data
2,804.30632    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap:
TYT Live PriceLast checked at - London Stock Exchange

Intraday Toyota Motor Share Chart

Stabilisation Notice

Today 09:49

RNS Number : 2155J
J.P. Morgan Securities PLC.
22 June 2026
Β 

22nd June 2026

Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.

Toyota Motor Corporation

Β 

Pre-stabilisation Period Announcement

Β 

J.P. Morgan Securities PLC, (contact: Robert Chambers +442071342468) hereby gives notice, as Stabilisation Coordinator, that the Stabilising Manager(s) named below may stabilise the offer of the following securities in accordance with Commission Delegated Regulation EU/xxx/2016 under the Market Abuse Regulation (EU/596/2016).

The securities:

Issuer:

Toyota Motor Corporation

Obligor (if any):

N/A

Aggregate nominal amount:

EUR 4yrFXD - 500M WNG

EUR 8yrFXD - 500M WNG

Description:

EUR RegS Registered Senior Unsecured FXD notes

Β 

Listing: Singapore Exchange Securities Trading Limited (SGX-ST)

Offer price:

TBC

Other offer terms:

EUR 100k x 1k

Stabilisation: Relevant Stabilisation regulation appliesΒ 

Stabilisation Manager(s):

J.P. Morgan Securities PLC (Stabilisation coordinator)

BOFA Securities (Stabilisation manager)

Morgan Stanley (Stabilisation manager)

Barclays (Stabilisation manager)

BNP Paribas (Stabilisation manager)

Stabilisation period expected to start on:

22nd June 2026

Stabilisation period expected to end no later than:

22nd July 2026

Existence, maximum size and conditions of use of over‑allotment facility:

The Stabilisation Manager(s) may over-allot the securities in an amount not exceeding 5% of the aggregate nominal amount stated above.

Stabilisation trading venue:

Over the counter, TBC

Β 

In connection with the offer of the above securities, the Stabilising Manager(s), or persons acting on behalf of the Stabilising Manager(s) may over-allot the securities, provided that the aggregate principal amount of the securities allotted does not exceed 105 percent of the aggregate principal amount of the securities, or effect transactions with a view to supporting the market price of the securities at a level higher than that which might otherwise prevail. However, stabilisation may not necessarily occur and any stabilisation action, if begun, may cease at any time, but it must end no later than the earlier of 30 days after the issue date of the securities and 60 days after the date of allotment of the securities.

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

This announcement and the offer of the securities to which it relates are only addressed to and directed at persons outside the United Kingdom and persons in the United Kingdom who have professional experience in matters related to investments or who are high net worth persons within Article 12(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and must not be acted on or relied on by other persons in the United Kingdom.

In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, any EEA Member State that has implemented Directive 2003/71/EC (together with any applicable implementing measures in any Member State, the "Prospectus Directive") before the publication of a prospectus in relation to the securities which has been approved by the competent authority in that Member State in accordance with the Prospectus Directive (or which has been approved by a competent authority in another Member State and notified to the competent authority in that Member State in accordance with the Prospectus Directive), this announcement and the offer are only addressed to and directed at persons in that Member State who are qualified investors within the meaning of the Prospectus Directive (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in that in that Member State

This announcement is not an offer of securities for sale into the United States. The securities have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There will be no public offer of securities in the United States.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
STAEAPKAALKKEEA
Date   Source Headline
22nd Jun 20269:49 amRNSStabilisation Notice
18th Jun 20268:00 amRNSVoting Results of General Shareholders' Meeting
18th Jun 20268:00 amRNSResolutions Adopted at Shareholders’ Meeting
18th Jun 20268:00 amRNSNotice of Partial Amendment to the ESOP trust
17th Jun 20269:00 amRNSChanges to Board Members and Executive Structure
17th Jun 20269:00 amRNSCorporate Governance Report
15th Jun 20268:00 amRNSRecording of Gains on Sale of Shares
10th Jun 20268:00 amRNSExecutive Summary of the Securities report
28th May 202611:30 amRNSNotice Concerning Company Split
20th May 20265:30 pmRNSNotice Concerning Company Split
13th May 20268:00 amRNSNotice of Convocation
8th May 20268:00 amRNSFY2026 Presentation Documents
8th May 20268:00 amRNSFY2026 Financial Summary
8th May 20268:00 amRNSDisposition of Treasury Stock
8th May 20268:00 amRNSGeneral Shareholders’ Meeting
28th Apr 20269:00 amRNSTender Offer Results and Completion of Repurchase
30th Mar 20268:00 amRNSTender Offer for Own Shares / Repurchase of Shares
6th Mar 20268:00 amRNSConcerning Changes of Tender Offer for Own Shares
5th Mar 20268:00 amRNSExecutive and senior management change notice
25th Feb 20268:00 amRNSShareholder Benefits (Record Date: 31 Mar. 2026) 
6th Feb 20268:00 amRNSFY2026 3rd Quarter Financial Summary
6th Feb 20268:00 amRNSFY2026 3rd Quarter Financial Results Presentation
6th Feb 20268:00 amRNSNotification of Change of Representative Directors
14th Jan 20269:00 amRNSConcerning Changes of Tender Offer for Own Shares
28th Nov 20258:00 amRNSFinancial Statements (FY2025 First Half)
28th Nov 20258:00 amRNSSummary of First Half Secrities Report
5th Nov 20258:00 amRNSFY2026 2nd Quarter Financial Results Presentation
5th Nov 20258:00 amRNSFY2026 2nd Quarter Financial Summary
6th Oct 202510:00 amRNSConcerning Progress of Tender Offer for Own Shares
9th Sep 20258:00 amRNSProgress Report on Measures to Prevent Recurrence
7th Aug 20258:00 amRNSFY2026 1st Quarter Financial Results Presentation
7th Aug 20258:00 amRNSFY2026 1st Quarter Financial Summary
7th Aug 20258:00 amRNSTreasury Stock Disposition for Compensation Plan
18th Jun 20251:00 pmRNSSummary of Annual Securities Report
18th Jun 20259:00 amRNSCorporate Governance Report
13th Jun 20258:00 amRNSVoting Results of General Shareholders' Meeting
13th Jun 20258:00 amRNSResolutions Adopted at Shareholders’ Meeting
12th Jun 20258:00 amRNSNotification of changes to Executive Structure
10th Jun 20259:00 amRNSNotice About Change in Consolidated Subsidiary
3rd Jun 20258:00 amRNSTender Offer for Own Shares and Other Matters
30th May 20259:30 amRNSprogress report on recurrence prevention measures
28th May 20258:00 amRNSOur View on ISSs Voting Recommendation
13th May 20258:00 amRNSNotice of Convocation
8th May 20259:00 amRNSFY2025 Presentation Documents
8th May 20258:00 amRNSPartial Amendments to Articles of Incorporation
8th May 20258:00 amRNSGeneral Shareholders' Meeting
8th May 20258:00 amRNSFY2025 Financial Summary
8th May 20258:00 amRNSDisposition of Treasury Stock
28th Apr 20257:00 amRNSRegarding Certain Media Report
24th Apr 20258:00 amRNSNon-Consolidated Financial Results of Hino Motors

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.